Robert Naclerio to Immunoglobulin E
This is a "connection" page, showing publications Robert Naclerio has written about Immunoglobulin E.
Connection Strength
1.839
-
Uncharted Waters: Challenges in the Era of Biologic Therapies for Nasal Polyposis. J Allergy Clin Immunol Pract. 2019 01; 7(1):68-70.
Score: 0.641
-
Total IgE levels do not change 1 year after endoscopic sinus surgery in patients with chronic rhinosinusitis. Int Arch Allergy Immunol. 2006; 139(2):146-8.
Score: 0.265
-
Nasal provocation with allergen induces a secondary serum IgE antibody response. J Allergy Clin Immunol. 1997 Oct; 100(4):505-10.
Score: 0.150
-
Total IgE serum levels correlate with sinus mucosal thickness on computerized tomography scans. J Allergy Clin Immunol. 1997 Oct; 100(4):563-8.
Score: 0.150
-
Dual function of novel pollen coat (surface) proteins: IgE-binding capacity and proteolytic activity disrupting the airway epithelial barrier. PLoS One. 2013; 8(1):e53337.
Score: 0.108
-
A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010 09; 48(3):318-24.
Score: 0.092
-
Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy. 2006 Sep; 61(9):1086-96.
Score: 0.070
-
Effect of seasonal ragweed exposure on immunoglobulin E antiragweed antibodies in cultures of peripheral mononuclear cells, plasma and nasal secretions. Int Arch Allergy Appl Immunol. 1985; 78(3):225-32.
Score: 0.062
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy. 2020 07; 75(7):1546-1554.
Score: 0.045
-
A double-blind study of the discontinuation of ragweed immunotherapy. J Allergy Clin Immunol. 1997 Sep; 100(3):293-300.
Score: 0.037
-
Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies. J Allergy Clin Immunol. 1993 Nov; 92(5):717-21.
Score: 0.029
-
Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol. 1992 Apr 01; 148(7):2223-8.
Score: 0.026
-
Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy. J Allergy Clin Immunol. 1992 Feb; 89(2):519-29.
Score: 0.025
-
Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol. 1991 Apr; 87(4):855-66.
Score: 0.024
-
Ragweed IgE and IgG4 antibody in nasal secretions during immunotherapy. Clin Exp Allergy. 1990 Sep; 20(5):571-9.
Score: 0.023
-
Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol. 1987 Jul 15; 139(2):506-12.
Score: 0.018
-
Is leukotriene B4 an important mediator in human IgE-mediated allergic reactions? Am Rev Respir Dis. 1987 Jun; 135(6 Pt 2):S42-5.
Score: 0.018
-
IgE-mediated leukotriene release in vitro and in vivo. Trans Assoc Am Physicians. 1984; 97:260-7.
Score: 0.014
-
The role of prostaglandin D2 in IgE-mediated reactions in man. Trans Assoc Am Physicians. 1982; 95:221-8.
Score: 0.013
-
Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophils. Pulm Pharmacol Ther. 1997; 10(2):97-104.
Score: 0.009
-
Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis. Clin Exp Allergy. 1990 Sep; 20(5):491-500.
Score: 0.006
-
Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. J Allergy Clin Immunol. 1989 Sep; 84(3):390-9.
Score: 0.005
-
The pharmacologic control of mediator release from human basophils and mast cells. Respiration. 1986; 50 Suppl 2:116-22.
Score: 0.004
-
Role of human basophils and mast cells in the pathogenesis of allergic diseases. J Allergy Clin Immunol. 1985 Aug; 76(2 Pt 2):369-74.
Score: 0.004